Stepanov et al., 1996 - Google Patents
Development of novel vaccines against anthrax in manStepanov et al., 1996
View PDF- Document ID
- 15948489383375469827
- Author
- Stepanov A
- Marinin L
- Pomerantsev A
- Staritsin N
- Publication year
- Publication venue
- Journal of biotechnology
External Links
Snippet
It has been shown that antianthrax immunity induced by the novel vaccine proposed has not only antitoxic, but also antispore character. The whole complex of antigens, namely surface spore antigens, surface antigens of cell wall and toxin components is required for the …
- 229960005486 vaccines 0 title abstract description 56
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stepanov et al. | Development of novel vaccines against anthrax in man | |
| Holder et al. | Flagellar preparations from Pseudomonas aeruginosa: animal protection studies | |
| Avila-Calderón et al. | A history of the development of Brucella vaccines | |
| Vasfi Marandi et al. | Role of outer membrane protein H (OmpH)-and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida | |
| US4721617A (en) | Vaccine against lyme disease | |
| JP2004536106A (en) | Mycoplasma bovis vaccine and method for reducing pneumonia in animals | |
| Holt et al. | Immunisation of pigs with killed cultures of Streptococcus suis type 2 | |
| JP3178720B2 (en) | Pasteurella multocida toxoid vaccine | |
| Caro et al. | Relationship between the immune response and protection conferred by new designed inactivated vaccines against ovine enzootic abortion in a mouse model | |
| Holt et al. | Protective effect of sera raised against different fractions of Streptococcus suis type 2 | |
| Waite et al. | Capsular polysaccharide conjugate vaccines against contagious bovine pleuropneumonia: immune responses and protection in mice | |
| US5429818A (en) | Non-capsulated mutants of Actinobacillus pleuropneumoniae useful as vaccines | |
| US5059419A (en) | Streptococcus suis antiserum and its use in treating Streptococcus suis infections | |
| RU2043771C1 (en) | Vaccine against escherichiosis in animals | |
| Woodward | Rickettsial vaccines with emphasis on epidemic typhus-initial report of an old vaccine trial | |
| RU2159127C1 (en) | Vaccine for preventing pseudomonosis of fur-bearing animals | |
| Dorner et al. | Immunity to Escherichia coli in piglets: the role of colostral antibodies directed against heat labile enterotoxin in experimental neonatal diarrhoea | |
| De Cueninck et al. | Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide | |
| US6790446B2 (en) | Campylobacter vaccine | |
| Lam et al. | Immunization of chickens with temperature-sensitive mutants of Mycoplasma gallisepticum | |
| US20240197851A1 (en) | A vaccine for protection against streptococcus suis serotype 9, sequence type 16 | |
| Roshdy et al. | Preparation of a newly developed trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale vaccine with an evaluation of its protective efficacy in chickens | |
| RU2761379C1 (en) | Polyvalent inactivated vaccine against swine streptococcosis, method for its production and use | |
| RU2521651C1 (en) | STRAINS OF BACTERIA Moraxella bovoculi "SH-CH6 N-DEP" USED TO MANUFACTURE DIAGNOSTIC PREPARATIONS AND VACCINES AGAINST INFECTIOUS KERATOCONJUNCTIVITIS OF CATTLE | |
| RU2824493C1 (en) | Strain of bacteria actinobacillus pleuropneumoniae serotype 8, intended for production of mono- and polyvalent immunogenic compositions aimed at specific prevention of porcine actinobacillus pleuropneumoniae |